Access to capital is a major hurdle for biotechnology companies of every size. BioNJ is pleased to serve as a clearinghouse for funding information, opportunities and resources.
Public Funding Resources
The Centers for Disease Control and Prevention (CDC) will begin making awards totaling nearly $60 million to states, cities, and territories to support efforts to protect Americans from Zika virus disease and adverse health outcomes that can result from Zika infection, including the serious birth defect microcephaly.
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative research proposals of interest to the Biological Technologies Office (BTO). Proposed research should investigate leading edge approaches that enable revolutionary advances in science, technologies, or systems at the intersection of biology with engineering and the physical and computer sciences. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of the art. BTO seeks unconventional approaches that are outside the mainstream, challenge assumptions, and have the potential to radically change established practice, lead to extraordinary outcomes, and create entirely new fields.
The U.S. Economic Development Administration’s investment policy is designed to establish a foundation for sustainable job growth and the building of durable regional economies throughout the United States. This foundation builds upon two key economic drivers – innovation and regional collaboration. Innovation is key to global competitiveness, new and better jobs, a resilient economy, and the attainment of national economic goals. Regional collaboration is essential for economic recovery because regions are the centers of competition in the new global economy and those that work together to leverage resources and use their strengths to overcome weaknesses will fare better than those that do not. EDA encourages its partners around the country to develop initiatives that advance new ideas and creative approaches to address rapidly evolving economic conditions.
The i6 Challenge is a multi-agency grant that encourages and rewards innovative, groundbreaking ideas that accelerate technology commercialization, new venture formation, job creation, and economic growth across the United States.
This site provides a list of all government funded grant opportunities of interest for R&D in biomed, medtech, bioscience and life science.
Greater Newark Enterprises Corporation (GNEC) is a community development corporation, and Certified CDFI, established in 2005. GNEC provides financial assistance and training to small businesses in a variety of topical areas, including financial literacy for entrepreneurs, business planning and business management across a myriad of industries. Economic development is the primary purpose of The Greater Newark Enterprise Corporation, and the organization carries out that mission by financing small business growth and development, job creation, community facilities, and providing financial services for low-income families. GNEC is organized to encourage and assist commercial enterprises, including those owned by minority, women, and low-income entrepreneurs possessing the capability to operate successful business concerns.
PACT’s mission is to create a strategic hub for the region’s emerging growth companies in the information technology, clean technology, and life sciences industries, manifesting in a competitive edge for the Greater Philadelphia region.
The national Business Incubation Association (NBIA) is the world’ leading organization advancing business incubation and entrepreneurship. It provides thousands of professionals with the information, education, advocacy and networking resources to bring excellence to the process of assisting early-stage companies worldwide. (740) 593-4331
NCATS seeks to increase small business participation in federally supported research and development as well as private-sector commercialization of technology developed with federal support. The Center achieves this through the federal government’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Newark’s leading broad-based business organization. With services that include frequent networking opportunities, first class business information programs, strong business advocacy and one-on-one member attention, NRBP is building business for a greater Newark. (973) 522-0099
NJAWBO is the oldest statewide women business owners’ organization in the United States. Its primary objective is to support and encourage business ownership by women. Since 19878, NJAWBO has helped women achieve their business visions by providing them with the tools to develop and grow their enterprises. (609) 799-5101
The New Jersey Business Incubation Network (NJBIN) is a collaborative statewide community of business experts and resource facilities dedicated to enhancing the commercial success of early stage and expansion stage entrepreneurial companies, growing higher paying jobs, and supporting the economic growth strategy for the state. Early stage and expansion stage companies receive critical support services and flexible space in a professional business environment.
The EDA is a self-supporting, independent state agency whose mission is to stimulate business development, job creation and community revitalization throughout the state. From its large portfolio of varied programs and services, the EDA can assist entrepreneurs with low-interest financing assistance, including tax-exempt and taxable bond financing, loans, loan guarantees, venture capital and business and tax incentives, and with training and technical assistance programs.
Mailing Address: PO Box 990, Trenton, NJ 08625-0990
Street Address: 36 West State Street, Trenton, NJ 08625
The New Jersey Economic Development Authority (EDA) is committed to nurturing the development of new technologies and ensuring that the State continues to be a leader in innovation. That’s why we offer a full range of programs and services to fuel the continuing growth of core industries vital to the State’s economy, including: technology, life sciences, clean energy and information and communication technologies.
Economic Development in New Jersey requires a new course in order to create the optimum conditions for business growth and job creation in the State. Governor Christie recognized the need for change and consolidated all State economic development activities under the leadership of Lieutenant Governor Kim Guadagno, creating the New Jersey Business Action Center (BAC) in the Department of State.
The New Jersey Business Action Center plays a key role in helping grow, retain and attract business to the State. The center serves as a “one-stop” shop for business. The team at the Center works to encourage entrepreneurship by supporting New Jersey’s businesses of all sizes, supporting global competitiveness of New Jersey companies, as well as to promote the State’s attractiveness as a vacation destination and business investment location nationally and internationally. (866) 534-7789 or BusinessActionCenter@sos.state.nj.us
The New Jersey Small Business Development Center was established by Congress in 1978 as one of the first national SBDC pilot projects resulting from the passage of Public Law 96-302. At present the NJSBDC network is composed of the headquarters located at Rutgers Business School – Newark and New Brunswick, and 12, full-service, regional centers, and an additional 28 affiliate (or satellite) offices located throughout the state. Regional centers are hosted by and affiliated with a two- and four-year college and university business programs with a major footprint for comprehensive small business assistance and outreach.
The Small Business Innovation Research (SBIR) program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) that has the potential for commercialization. Through a competitive awards-based program, SBIR enables small businesses to explore their technological potential and provides the incentive to profit from its commercialization. By including qualified small businesses in the nation’s R&D arena, high-tech innovation is stimulated and the United States gains entrepreneurial spirit as it meets its specific research and development needs.
SCORE is a nonprofit association dedicated to helping small businesses get off the ground, grow and achieve their goals through education and mentorship. We have been doing this for nearly 50 years. Because our work is supported by the U.S. Small Business Administration (SBA), and thanks to our network of 11,000+ volunteers, we are able to deliver our services at no charge or at very low cost.
Our mission is to provide the tools for women to successfully own, operate and grow their small businesses, thereby investing financially, intellectually and emotionally in their community. (973) 507-9700
Brick City Development Corporation (BCDC), the primary economic development catalyst for Newark, New Jersey, was organized to retain, attract, and grow businesses, enhance small and minority business capacity, and spur real estate development within the city. Brick City Development Corporation initiates and executes economic development activities to produce and sustain economic growth, generate jobs, and create wealth for the citizens of Newark. (973) 273-1040
Launched in 2006, First State Innovation (FSI) is a privately led initiative that focuses on increasing Delaware’s entrepreneurial capacity. FSI has accomplished this by helping technology-based and early stage businesses find traditional seed capital, alternative funding, skilled human capital, commercialization assistance, intellectual capital, and other entrepreneurial resources. (302) 888-5756
The New Jersey Technology Council (NJTC) provides business support, networking opportunities, information, advocacy, and recognition of technology companies and their leaders. Founded in 1996, NJTC’s member companies work together to support their own enterprises while advancing New Jersey’s status as a leading technology center in the United States. (856) 787-9700
Philadelphia Industrial Development Corporation (PIDC) is a private, not-for-profit Pennsylvania corporation, founded in 1958 by the City of Philadelphia and the Greater Philadelphia Chamber of Commerce to promote economic development throughout the city. PIDC’s central strategy is to leverage financing and real estate resources to retain and to grow employment in Philadelphia. PIDC also coordinates tax incentive and work force development programs offered by the City and the Commonwealth. (215) 496-8020
The mission of the Center is to build a world-class research-driven, teaching and practitioner-oriented urban entrepreneurship and economic development program that will transform the economy of the City of Newark, New Jersey, and other urban centers; create wealth in urban communities; and be a model for all urban universities. (973) 353-1288
Technology and life-science startups face many challenges along the way to becoming profitable businesses and dynamic participants in the economic life of New Jersey and the nation. Meeting the challenges of successful commercialization requires a broad range of knowledge and resources – from finding the right working space and attracting investment capital to building staff and developing effective business plans and marketing strategies. Since 1988, the EDC – the Enterprise Development Center – operated by New Jersey institute of technology (NJIT) has given startups a critical edge in all of these areas. (973) 643-4063
IFEL takes a holistic, hands-on approach to helping entrepreneurs grow their business. The focus is on minority and female urban businesses with a strong vision and viable business model. (973) 353-0611
The NJIT Procurement Technical Assistance Center (PTAC) provides contractual and technical assistance to small-established New Jersey businesses interested in marketing their products, services to federal, state and local governments. The center operates under a cost sharing cooperative agreement bet33ween the Department of defense and Jew Jersey Institute of Technology. (973) 596-3105
The Rowan Innovation Venture Fund is a University-based, $5 million private-equity fund. The Rowan University Foundation established the Fund in 2014 to provide early-stage funding to companies that have developed and tested projects and products that are ready to compete in the marketplace. The Fund welcomes applications from individuals and companies in their early-seed stage that have obtained some previous financial support, including from friends and family.
The QED Program is a multi-institutional proof-of-concept program that provides business development support for academic researchers developing early-stage life science and healthcare IT technologies with high commercial potential.
Private Funding Resources
Allied-Bristol Life Sciences LLC (ABLS) is a first-of-its-kind joint venture between Allied Minds and Bristol-Myers Squibb Co. that aims to deliver the important medicines for tomorrow. ABLS works with researchers at leading U.S. universities to identify discoveries with highly promising commercial and therapeutic potential, and supports the development needed to take these early-stage opportunities from the lab to the market place.
The Science & Technology Accelerator is tasked with identifying the most revolutionary, game-changing innovations, which are capable of dramatically improving cardiovascular health of millions of people, and assisting them from scientific validation through proof of concept. At that point, having been “de-risked” sufficiently, they can gain traction with industry or private equity sources of funding to take them to the finish line.
For over 25 years, Ben Franklin Technology Partners of Southeastern PA has invested in innovative enterprises and created commercialization pathways and partnerships that generate wealth through science and technology. (215) 972-6700
BioAdvance provides funding to start-up life sciences companies in Southeastern Pennsylvania through its $20 million Greenhouse Fund. (610) 230-0544
Discovery Partnerships with Academia is a new approach to early drug discovery. The concept is simple but powerful: bring together the insight and creativity of the academic world with the drug discovery expertise of GlaxoSmithKline (GSK) to establish truly integrated partnerships that can translate innovative research into medicines that benefit patients.
Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
By providing a platform for idea-sharing, Open Innovation Drug Discovery lowers the barrier for collaborations between investigators working inside and outside an organization. Free exchange of ideas between investigators across traditionally impregnable organizational walls contributes to the advancement of Science.
Lilly is a key collaborator in the Dementia Discovery Fund (DDF), which aims to accelerate the discovery and development of new treatments for dementia. This first-ever global dementia research fund will invest in research into treatments for the condition. Read more.
The NJIT Highlanders Angel Network, Inc. is comprised of accredited investors (based on the guidelines specified by the Securities and Exchange Commission) who are NJIT Alumni, NJIT faculty/staff, private investors, large and small business executives, and industry professionals. They possess a full range of skills representing multiple industries. The NJIT Highlanders Angel Network, Inc. investors may provide investment capital, mentoring, and access to a network of resources to support High-Tech Life Science & Technology related businesses (e.g. bioscience, information technology, advanced energy, electronics controls, sensors, and advanced materials industries). The Network also promotes entrepreneurship activities at NJIT through exposure to Angel investors who will make investments in worthy business ventures. When applicable, the NJIT Highlanders Angel will assist in forging partnerships for entrepreneurial companies. The NJIT Highlanders Angel Network, Inc. is associated with NJIT. The NJIT Highlanders Angel Network, Inc. is an independent non-profit corporation dedicated to providing a forum for angel investors.
Jumpstart NJ Angel Network is a member-led, angel group of successful serial entrepreneurs, business executives and venture capitalists which actively invests in early-stage technology ventures in the Mid-Atlantic region and beyond.
JumpStart provides intensive, high-impact assistance to diverse Northeast Ohio founders leading high potential early-stage companies, working one-on-one with entrepreneurs to establish and achieve value-creating milestones of growth. These include things such as raising capital, generating revenue, hiring employees, forming a board of directors, testing the commercial viability of a product or service, and moving a product or service into the market.
With nearly 2,250 accredited angel investor members dispersed throughout 47 chapters on three continents, Keiretsu Forum is an investor – private equity community which receives applications for funding consideration. Keiretsu Forum Mid-Atlantic has Chapters in NY, Philadelphia, DC/Baltimore and Pittsburgh. In 2016, a total of $7.8m was invested across 37 companies.
Search for groups with the following categories: NJ Tech, Brick City Tech, Princeton, Madison, Morris Tech, Innovation Technology, Launch NJ, Jersey Shore, Scarlet, etc.
1st Pitch Life Science is organized by MABA (Mid Atlantic Bio Angels) a life science investor group, to encourage and educate aspiring life science entrepreneur who know they may be too earl to seek investment but want the opportunity to practice their pitch and to receive construction criticism from experienced and knowledgeable professionals.
PCCI provides complimentary executive level consulting services to help early-stage life sciences companies to succeed. We provide our members and their guest with an informal networking venue supporting our mission to help Pharma start-up companies move forward and to facilitate and create business opportunities for PCCI members and their guests.
Venture Capital Firms
Leading Edge Ventures provide venture capital financing and guidance to exceptional entrepreneurs whose innovative companies are transforming their markets
The National Association of Seed and Venture Funds is an organization of innovation capital leaders: private, public and non-profit organizations committed to building their local economies by investing in local entrepreneurs.
Second Venture powers Venture Exchange Platforms to enable Venture Capital Funds & Angel Groups to better manage their dealflow. 800-461-5509
A monthly meeting of entrepreneurs and service providers addressing issues of financing for early stage companies. Twice a year, an Entrepreneurs Expo & Elevator Pitch Olympics are held. (973) 267-4200 x193
Corporate Venture Funds
Investment Preferences: Life sciences companies across biotech/pharma, medical devices and diagnostics.
Investment Preferences:Private companies with innovative medicines, diagnostics and technologies.
Investment Preferences: Life sciences and health sector companies.
Investment Preferences: Private companies that develop molecules, vaccines, pharma technology and platforms.
Investment Preferences: Early-stage therapeutics.
Investment Preferences: Biotech companies focused on therapeutics.
Investment Preferences: Early-stage, high risk areas enabling growth of novel progress and technology.
Investment Preferences: Biotech companies building multi-product pipelines (pharma and diagnostics).
Investment Preferences: Start-ups focused on therapeutics.
Investment Preferences: Early-stage companies that benefit Patients in therapeutic areas.
Investment Preferences: Enhancements in Patient care through innovative science.
Investment Preferences: Early/late stage life sciences companies in North America and Europe.
Investment Preferences: Early stage companies that develop the next generation technologies and products to serve unmet medical need and improve patient outcomes.
Investment Preferences: Early-stage innovative life sciences companies.
Investment Preferences: Biopharma, biotech and pharma startups.
Adenoid Cystic Carcinoma Research Foundation
Elisa U. Pardee Foundation
National Foundation for Cancer Research
The V Foundation for Cancer Research
Conquer Cancer Foundation
Alliance for Cancer Gene Therapy
Blindness and Hearing
Rare Genetic Disorders
Spinal Cord Injury
National Foundation for Infectious Diseases
Hepatitis B Foundation
Hepatitis C Foundation
Medicines for Malaria Venture
American Society of Tropical Medicine and Hygiene
amFAR Making AIDS History